Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Superior Visualization of Intracavernous Cranial Nerves with 3D T1 VIBE Compared with MPRAGE in Patients with Neuro-Ophthalmic Symptoms.

AJNR. American journal of neuroradiology·2026
Same author

Efferocytosis: Gateway for tissue resolution.

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism·2026
Same author

Mutant KRAS in brain endothelial cells promotes vascular inflammation and impairs vascular integrity in brain arteriovenous malformation.

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism·2026
Same author

Endothelial oncogenic KRAS mutation drives the dynamics of microglia and macrophages in brain arteriovenous malformation.

JCI insight·2026
Same author

Consensus Review of Perioperative Immune Modulation for Endovascular Thrombectomy Following Ischemic Stroke.

Stroke·2026
Same author

NMR-driven insights into the evolutionary adaptation and dynamic regulation of Mycobacterium tuberculosis adenylate kinase: The critical role of glycine-mediated flexibility.

Biochemical and biophysical research communications·2026

Related Experiment Video

Updated: Feb 23, 2026

Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke
08:53

Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke

Published on: June 6, 2025

1.9K

CD36: a multi-modal target for acute stroke therapy.

Sunghee Cho1, Eunhee Kim

  • 1Burke/Cornell Medical Research Institute, White Plains, New York, New York 10605, USA. suc2002@med.cornell.edu

Journal of Neurochemistry
|April 28, 2009
PubMed
Summary
This summary is machine-generated.

CD36, a known inflammatory receptor, plays a significant role in cerebral ischemia pathogenesis. Targeting CD36 offers a promising therapeutic strategy for stroke, especially in patients with hyperlipidemia and diabetes.

More Related Videos

Evaluating Cell Death Signaling by Immunofluorescence in a Rat Model of Ischemic Stroke
11:32

Evaluating Cell Death Signaling by Immunofluorescence in a Rat Model of Ischemic Stroke

Published on: January 3, 2025

1.6K
Author Spotlight: Establishing a Reliable Distal MCA Occlusion Model in Mice for Stroke Research
07:34

Author Spotlight: Establishing a Reliable Distal MCA Occlusion Model in Mice for Stroke Research

Published on: December 15, 2023

3.4K

Related Experiment Videos

Last Updated: Feb 23, 2026

Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke
08:53

Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke

Published on: June 6, 2025

1.9K
Evaluating Cell Death Signaling by Immunofluorescence in a Rat Model of Ischemic Stroke
11:32

Evaluating Cell Death Signaling by Immunofluorescence in a Rat Model of Ischemic Stroke

Published on: January 3, 2025

1.6K
Author Spotlight: Establishing a Reliable Distal MCA Occlusion Model in Mice for Stroke Research
07:34

Author Spotlight: Establishing a Reliable Distal MCA Occlusion Model in Mice for Stroke Research

Published on: December 15, 2023

3.4K

Area of Science:

  • Neuroscience
  • Immunology
  • Cardiovascular Research

Background:

  • CD36 is implicated in atherosclerosis, inflammation, and lipid metabolism.
  • Its role in cerebral ischemia remains largely unexplored.
  • CD36 functions as a prototypic inflammatory receptor.

Purpose of the Study:

  • To establish CD36 as a key contributor to cerebral ischemia pathogenesis.
  • To highlight CD36 as a potential therapeutic target for stroke.
  • To explore the influence of hyperlipidemia and diabetes on CD36-mediated stroke.

Main Methods:

  • Review of existing literature on CD36 functions.
  • Analysis of CD36's role in experimental models of cerebral ischemia.
  • Focus on risk factors like hyperlipidemia and diabetes.

Main Results:

  • CD36 contributes to the pathogenesis of cerebral ischemia.
  • Clinical trial failures may stem from inadequate animal models.
  • Hyperlipidemia and diabetes modulate CD36 responses in stroke.

Conclusions:

  • Blocking CD36 offers a novel therapeutic strategy for stroke.
  • Clinically relevant models are crucial for translational studies.
  • Understanding CD36's role can lead to effective treatments for stroke victims.